Follow The Filings

CRVSCorvus Pharmaceuticals Inc.

Q2 2026 13F holders among managers we track Latest ownership dossier

Ticker
CRVS
Type
Equity
Class
COM
Total reported value (long equity)
Manager Report date Value Shares